home > drugs a-z list > proquad (measles mumps rubella varicella vaccine live) drug center > proquad (measles mumps rubella varicella vaccine live) drug - medication guide and patient information

The health care provider should provide the required vaccine information to the patient, parent, or guardian.

The health care provider should inform the patient, parent, or guardian of the benefits and risks associated with vaccination.

The health care provider should tell the vaccine recipient or his or her parent or guardian that the vaccine recipient should avoid use of salicylates for 6 weeks after vaccination with ProQuad (see DRUG INTERACTIONS).

Female vaccine recipients of childbearing age should be told to avoid pregnancy for 3 months following vaccination.

Patients, parents, or guardians should be told that vaccination with ProQuad (measles mumps rubella varicella vaccine live) may not offer 100% protection from measles, mumps, rubella, and varicella infection.

Patients, parents, or guardians should be instructed to report any adverse reactions to their health care provider. The U.S. Department of Health and Human Services has established a Vaccine Adverse Event Reporting System (VAERS) to accept all reports of suspected adverse events after the administration of any vaccine, including but not limited to the reporting of events required by the National Childhood Vaccine Injury Act of 1986. The VAERS toll-free number for VAERS forms and information is 1-800-822-7967 or information may be submitted electronically via http://www.fda.gov/cber/vaers/vaers.htm

Last reviewed on RxList: 2/14/2008
This monograph has been modified to include the generic and brand name in many instances.